Bank of New York Mellon’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
SAM
ACM
CUAMC
PFSRSONJ
Bank of New York Mellon's PALI Position: Q2 2026 in Review
Bank of New York Mellon increased its Palisade Bio (PALI) stake by 2,599% in Q2 2026, buying an estimated $660K and bringing the position to 348,469 shares worth $728K. The position accounts for ﹤0.01% of the portfolio, ranked #3547.
Bank of New York Mellon first reported a position in PALI in Q1 2020 and has held it in 8 quarters since. 32 funds tracked by Wall St. Rank hold PALI as of Q2 2026.
- Bank of New York Mellon held 348,469 shares of Palisade Bio worth $728K as of Q2 2026.
- Bank of New York Mellon bought 335,557 Palisade Bio shares in Q2 2026, an estimated $660K.
- Palisade Bio made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3547 holding.
- Bank of New York Mellon first reported a position in Palisade Bio in Q1 2020 and has held it in 8 quarters since.
- 32 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.